CME Group Inc. (NASDAQ:CME) is Troy Asset Management Ltd's 10th Largest Position

Troy Asset Management Ltd trimmed its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 12.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 517,282 shares of the financial services provider's stock after selling 70,614 shares during the quarter. CME Group makes up about 3.7% of Troy Asset Management Ltd's portfolio, making the stock its 10th largest holding. Troy Asset Management Ltd owned about 0.14% of CME Group worth $114,138,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Norden Group LLC bought a new stake in shares of CME Group during the first quarter worth about $274,000. Empowered Funds LLC grew its holdings in CME Group by 24.5% during the 1st quarter. Empowered Funds LLC now owns 5,596 shares of the financial services provider's stock worth $1,205,000 after acquiring an additional 1,101 shares during the last quarter. QRG Capital Management Inc. increased its position in CME Group by 1.1% in the 1st quarter. QRG Capital Management Inc. now owns 31,412 shares of the financial services provider's stock valued at $6,763,000 after acquiring an additional 346 shares during the period. US Bancorp DE raised its stake in shares of CME Group by 4.4% during the first quarter. US Bancorp DE now owns 402,285 shares of the financial services provider's stock valued at $86,608,000 after acquiring an additional 17,102 shares during the last quarter. Finally, Avantax Advisory Services Inc. lifted its holdings in shares of CME Group by 4.5% during the first quarter. Avantax Advisory Services Inc. now owns 7,415 shares of the financial services provider's stock worth $1,596,000 after purchasing an additional 318 shares during the period. Institutional investors own 87.75% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Piper Sandler raised their target price on CME Group from $240.00 to $250.00 and gave the stock an "overweight" rating in a research report on Monday, October 28th. The Goldman Sachs Group lifted their price objective on CME Group from $195.00 to $198.00 and gave the stock a "sell" rating in a research note on Thursday, October 3rd. Keefe, Bruyette & Woods increased their target price on shares of CME Group from $212.00 to $213.00 and gave the company a "market perform" rating in a research report on Thursday, July 25th. JPMorgan Chase & Co. raised their price target on shares of CME Group from $187.00 to $191.00 and gave the stock an "underweight" rating in a report on Thursday, July 25th. Finally, TD Cowen assumed coverage on shares of CME Group in a research note on Thursday, September 26th. They issued a "hold" rating and a $221.00 price objective on the stock. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $222.73.

Insider Buying and Selling

In other news, Director Martin J. Gepsman sold 400 shares of the firm's stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Martin J. Gepsman sold 400 shares of the company's stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the sale, the director now owns 25,067 shares in the company, valued at $5,587,935.64. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the firm's stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 in the last quarter. Insiders own 0.30% of the company's stock.

CME Group Stock Up 1.6 %

CME stock traded up $3.62 during trading on Friday, reaching $225.66. 1,798,000 shares of the stock were exchanged, compared to its average volume of 1,483,283. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36. The firm's 50 day moving average is $221.72 and its 200 day moving average is $209.86. The firm has a market cap of $81.26 billion, a P/E ratio of 23.73, a price-to-earnings-growth ratio of 5.56 and a beta of 0.55.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analysts' expectations of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. CME Group's quarterly revenue was up 18.4% compared to the same quarter last year. During the same period last year, the business earned $2.25 EPS. As a group, research analysts forecast that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date of this dividend is Monday, December 9th. CME Group's payout ratio is presently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.